Welcome
Support Centre
12 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Thyroid dysfunction in the elderly: quantifying the association between sub-clinical disease and (i) atrial fibrillation (and thus stroke) (ii) depression and (iii) cognitive dysfunction. A community based survey and clinical trial of thyroxine therapy
Source of recordUK Trials
ISRCTNISRCTN23090699
Date ISRCTN assigned12/09/2002
Local reference number(s)226/657
Public titleThyroid dysfunction in the elderly: quantifying the association between sub-clinical disease and (i) atrial fibrillation (and thus stroke) (ii) depression and (iii) cognitive dysfunction. A community based survey and clinical trial of thyroxine therapy
Scientific title
AcronymBETS (Birmingham Elderly Thyroid Study)
Disease/condition/study domainThyroid dysfunction
Study hypothesisNot provided at time of registration
Design/methodologyCommunity based survey and randomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaPhase 1: Aged 65+
Phase 2a: Patients identified in Phase 1 to be suffering from sub-clinical hyperthyroidism
Phase 2b: Patients identified in Phase 1 to be suffering from sub-clinical hypothyroidism
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/01/2005
Anticipated end date01/01/2006
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsIntervention: Thyroxine replacement therapy. Dose to be increased by 25 mcg steps during 6 monthly period of monthly monitoring of thyroid function

Control: As for intervention group but placebo
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
PublicationsResults for community based survey: http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17003083
Sources of fundingThe Health Foundation (UK)
Sponsor nameThe Health Foundation (UK)
Sponsor details90 Long Acre
London
United Kingdom
WC2E 9RA
Sponsor telephone+44 (0)20 7257 8000
Sponsor fax+44 (0)20 7257 8001
Sponsor emailinfo@health.org.uk
Sponsor websitehttp://www.pppfoundation.org.uk/
Contact nameProfessor James V Parle
Contact detailsDepartment of Primary Care and General Practice
University of Birmingham
Edgbaston
United Kingdom
B15 2TT
Contact telephone+44 (0)121 414 6420
Contact fax+44 (0)121 414 7938
Contact emailj.v.parle@bham.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN23090699
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central